(1H-PYRAZOL-3-YL)-ACETIC ACID ETHYL ESTER, 95.0%, 5g

(R)-1-N-Cbz-Pyrrolidine-3-carboxylic acid, 95.0%, 1g

(R)-tert-butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate, 97%, 50mg

(3R,6S)-5-[(tert-butoxy)carbonyl]-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid, 97%, 1g

Multi-channel microliter pipette Pipetman® G 12-channel, 30 to 300 µl, P12x300G, 1 piece

Benzene D6, 99.5 at%D, 100 ml, glass packaging

(S)-tert-Butyl 1-(4-fluorobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

2,4,6-Trimethylbromobenzene, 98.0%, 25g

Tofisopam, 98%, 250mg

tert-Butyl naphthalen-1-ylcarbamate, 95.0%, 5g

Potassium hydroxide solution in 2-propanol, 0.1 mol/l - 0.1 N standard solution, 1 l, glass packaging

2,5-Difluoronitrobenzene, 98.0%, 500g

1-Methoxyphenazine, 97%, 100mg